Proactiveinvestors Australia

ARTICLES

• Friday, August 01, 2014
  TZ Limited achieves revenue guidance
  

  The momentum from achieving previous guidance of $8 million in accrued revenues, traction from new products and the roll out of customer installations programs underpins TZ Limited’s growth profile for the 2015 financial year.

• Friday, August 01, 2014
  Hazelwood Resources notches strong Ferrotungsten production
  

  A total of 254 tonnes of Ferrotungsten was lifted from the ATC project furnace and shipments of 275 tonnes occurred in the June quarter, with 80% provisional payment having been received. Cash receipts from product sales of $8.3 million were received during the quarter. Final sales settlements continued to be received throughout July.

• Friday, August 01, 2014
  Why did the Dow crash 316 points?
  

  There was a dramatic sell-off on Wall Street overnight, which managed to put the Dow in negative territory for 2014. Investors are trying to digest mixed messages from the Fed, uncertainty over rates concerns ahead of tomorrow's jobs data. The ASX SPI 200 is off 53 points to 5517.

• Thursday, July 31, 2014
  Regeneus to start safety trial for therapeutic human cancer vaccine
  

  The first-in-main trial for the personalised therapeutic human cancer vaccine is scheduled to begin in the first quarter of 2015. This has the potential to target a wide range of hard-to-treat cancers with a single product.

• Thursday, July 31, 2014
  Triton Minerals finds graphite outcropping at Balama South
  

  The discovery of large flake graphite mineralisation at Triton Mineral’s Balama South Project in Mozambique is interesting given the physical similarities of its outcropping with that at the Balama North Project.

• Thursday, July 31, 2014
  WPG Resources could have Tarcoola producing gold in 18 months
  

  With WPG Resources' Bob Duffin intent on fast tracking the Tarcoola gold project into production in South Australia in quick time, through conventional open pit operation with associated heap leach processing, it could be producing 20,000 ounces of gold per year.

• Thursday, July 31, 2014
  Freelancer marks strong cash flow to June
  

  The company’s net operating positive cash flow of $1.35 million for the first six months of 2014 is well above the $246,000 it made in the full year to 31 December 2013. The acquisition of Warrior Forum in April and the introduction of Warrior Payments should further expand its cash flow for the world's largest outsourcing marketplace.

• Thursday, July 31, 2014
  MRL Corporation assays show 99.2% Total Carbon, Sri Lanka
  

  Although still early days for MRL Corporation in Sri Lanka, the analytical results of 99.2% Total Carbon highlight the prospectivty of the area. With diamond drilling ongoing, near-term newsflow will continue.

• Thursday, July 31, 2014
  Aspire Mining and Noble look to Nuurstei for early coal exploration
  

  With potential for development into a small scale coking coal operation, the initial 20 hole drilling program at Aspire Mining and Noble Group’s Nuurstei Coal Project will be closely watched.

• Wednesday, July 30, 2014
  South Boulder Mines attracts funding from Hong Kong investor for Colluli
  

  By adding Kam Lung Investment Development Company as a strategic investor, South Boulder now have a Chinese partner to potentially secure an offtake agreement. South Boulder's shares are expected to climb today.

• Wednesday, July 30, 2014
  KGL Resources to present at Melbourne Investor Luncheon August
  

  Drilling continues to deliver high grade copper with many more samples to be assayed while a resource upgrade expected in August with a PFS in September, giving plenty to discuss.  KGL Resources managing director Simon Milroy will present at the Melbourne Investor Luncheon.

• Wednesday, July 30, 2014
  Admedus delivers more stellar results
  

  With overall sales of $7.8 million for  the year ended 30 June 2014, up from $7.4 million in the previous year, and closing cash of $19.5 million, Admedus is in a strong position to progress the launch and marketing of CardioCel® in Europe and the U.S.